Amalgamated Bank’s Cytosorbents Corp CTSO Stock Holding History

Amalgamated Bank’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,733	Closed	-$21K	–	3067
2022 Q1	$21K	Buy	+6,733	New	+$24.1K	﹤0.01%	2792

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's CTSO Position: Q2 2022 in Review

Amalgamated Bank sold out of Cytosorbents Corp (CTSO) in Q2 2022, closing a stake of 6,733 shares — an estimated $21K sold.

Amalgamated Bank first reported a position in CTSO in Q1 2022 and held it in 1 quarter. The position peaked at $21K in Q1 2022. 78 funds tracked by Wall St. Rank hold CTSO as of Q2 2022.

Amalgamated Bank reported no remaining Cytosorbents Corp position as of Q2 2022 after selling out during the quarter.
Amalgamated Bank sold 6,733 Cytosorbents Corp shares in Q2 2022, an estimated $21K.
Amalgamated Bank first reported a position in Cytosorbents Corp in Q1 2022 and held it in 1 quarter.
Amalgamated Bank's Cytosorbents Corp position peaked at $21K in Q1 2022.
78 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.